Namiko Hoshi
Overview
Explore the profile of Namiko Hoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito Y, Watanabe D, Okamoto N, Miyazaki H, Tokunaga E, Ku Y, et al.
Sci Rep
. 2025 Feb;
15(1):6112.
PMID: 39971758
The incidence of ulcerative colitis (UC) is on the rise also in Japan. Simultaneously, therapeutic options, including biologics and Janus kinase (JAK) inhibitors, have significantly expanded over the past decade....
2.
Sui Y, Hoshi N, Okamoto N, Inoue Y, Funatsu T, Ku Y, et al.
Biochem Biophys Res Commun
. 2025 Feb;
751:151446.
PMID: 39922055
Amino acid transporters are essential for supplying nutrients to cells and are implicated in tumor progression. L-type amino acid transporter 1 (LAT1) is reported to be overexpressed in various cancers,...
3.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Dec;
60(2):263-264.
PMID: 39729094
No abstract available.
4.
Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al.
J Gastroenterol
. 2024 Nov;
60(1):86-95.
PMID: 39607498
Background: A serum biomarker for diagnosing ulcerative colitis (UC) remains to be established. Although we recently reported an anti-integrin αvβ6 antibody (V6 Ab) for diagnosing UC with high sensitivity and...
5.
Shimizu Y, Hirano S, Salah M, Hoshi N, Yamashita Y, Fukumoto T, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594801
Background: Proanthocyanidins (PACs) from black soybean seed coat have antioxidant and anti-tumorigenic properties. We investigated the anti-tumor properties and mechanisms of action of PACs on colorectal cancer (CRC). Methods: We...
6.
Miyazaki H, Hoshi N, Ishida T, Nishioka C, Ouchi S, Shirasaka D, et al.
Sci Rep
. 2023 Nov;
13(1):20262.
PMID: 37985889
Not all patients with ulcerative colitis (UC) respond initially to treatment with biologic agents, and predicting their efficacy prior to treatment is difficult. Vedolizumab, a humanized monoclonal antibody against alpha...
7.
Miyazaki H, Watanabe D, Ito Y, Ikeda S, Okamoto N, Tokunaga E, et al.
Indian J Gastroenterol
. 2023 Jul;
42(5):701-707.
PMID: 37505394
Background/purpose Of This Study: It has been recommended that individuals with inflammatory bowel disease (IBD) be vaccinated against Coronavirus disease - 19 (COVID-19). Recently, we documented the incidence of side...
8.
Ito Y, Watanabe D, Ikeda S, Okamoto N, Miyazaki H, Tokunaga E, et al.
ACG Case Rep J
. 2023 Apr;
10(4):e01033.
PMID: 37091209
complex (MAC) is an important cause of opportunistic infections in immunosuppressed hosts, such as patients with HIV infection and solid organ transplant recipients. MAC disease usually presents in 4 distinct...
9.
Sui Y, Hoshi N, Ohgaki R, Kong L, Yoshida R, Okamoto N, et al.
J Gastroenterol
. 2023 Mar;
58(5):458.
PMID: 36884072
No abstract available.
10.
Sui Y, Hoshi N, Ohgaki R, Kong L, Yoshida R, Okamoto N, et al.
J Gastroenterol
. 2023 Feb;
58(5):444-457.
PMID: 36739585
Background: Amino acid transporters play an important role in supplying nutrition to cells and are associated with cell proliferation. L-type amino acid transporter 1 (LAT1) is highly expressed in many...